Warszawskie Centrum Medyczne Wawamed Sp. z o.o. (Poland)

Main Activities: General Medical and Surgical Hospitals

Secondary Activities: Pharmacies and Drug Stores | Administrative Management and General Management Consulting Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Miscellaneous Schools and Instruction | Ambulatory Health Care Services | Offices of Physicians | Offices of Dentists | Outpatient Care Centers | All Other Miscellaneous Ambulatory Health Care Services

Full name: Warszawskie Centrum Medyczne Wawamed Sp. z o.o.

Profile Updated: April 04, 2025

Warszawskie Centrum Medyczne Wawamed Sp. z o.o. is an enterprise in Poland, with the main office in Warsaw. It operates in the General Medical and Surgical Hospitals industry. It was first established on February 08, 2023. Over the same period, its total assets decreased by 91.76%.

Headquarters
Ul. Wronia 45/U2
Warsaw; Mazowieckie; Postal Code: 00-870

Contact Details: Purchase the Warszawskie Centrum Medyczne Wawamed Sp. z o.o. report to view the information.

Basic Information

Registered Capital:

Purchase the Warszawskie Centrum Medyczne Wawamed Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the Warszawskie Centrum Medyczne Wawamed Sp. z o.o. report to view the information.

Incorporation Date:

February 08, 2023

Ownership Details

Purchase this report to view the information.

70%

Purchase this report to view the information.

30%

Company Performance

Financial values in the chart are available after Warszawskie Centrum Medyczne Wawamed Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Total operating revenue

-100%▼

Operating profit (EBIT)

N/A

EBITDA

N/A

Net Profit (Loss) for the Period

N/A

Total Assets

-91.76%▼

Total Equity

-88.74%▼

Return on Equity (ROE)

N/A

Quick Ratio

9252.03%▲